Barry F. Uretsky
Professor
Also affiliated: Rutgers, The State University of New Jersey (2019–2020); Boston University (1976–1996); Northwestern University (1999); University of North Carolina at Chapel Hill (1997–2021); Creighton University (2011); Tufts University (1988–1993); University of London (1999); American Heart Association (1992); Cedars-Sinai Medical Center (1989); Merck & Co., Inc., Rahway, NJ, USA (United States) (1989); Tufts Medical Center (1988); Robert Wood Johnson University Hospital (2019–2020); Albert Einstein College of Medicine (1989); Arkansas Children's Hospital (2014); University of Minnesota (1989–1996); Abbott Northwestern Hospital (2018–2021); United States Department of Veterans Affairs (1988–2019); Mayo Clinic (1997–2009); Baystate Medical Center (1993); Thomas Jefferson University (1989); Henry Ford Health (1995); University of Alberta (1999–2000); St George's, University of London (1999); University of Pittsburgh (1982–2017); Duke University (1997–2001); University of California, San Francisco (1999–2000); University of Cologne (2006); University of Hull (1999–2000); Aarhus University (1999); University of Utah (1996); University of Pavia (1985); Brown University (1988); University of Arkansas Medical Center (2012–2025); Norwood Hospital (1979); Veterans Health Administration (1988); St Vincent Hospital (1989); John Sealy Hospital (2002); Castle Hill Hospital (2006); Newton Wellesley Hospital (1979); VA Boston Healthcare System (1988); Centre Hospitalier Universitaire Vaudois (2006); Aarhus University Hospital (1999–2000); Karolinska Institutet (1999–2000); University of Rochester Medicine (1989); University of Illinois Chicago (1997); Office of Science (2014); Central Arkansas Veterans Healthcare System (2008–2026); Ohio State University Hospital (1986); UPMC Presbyterian (1982–2017); Baystate Health (1993); Hôpital Pontchaillou (2006); Duke Medical Center (1999); Vall d'Hebron Hospital Universitari (1999); Children's Hospital of Pittsburgh (1990); Minneapolis Heart Institute Foundation (2020–2023); University of Pittsburgh Medical Center (1989–1996); Nouvelles Cliniques Nantaises (2006); University of Minnesota Medical Center (1996); Hôpital Jeanne d'Arc (2001); Dallas VA Medical Center (2017); Stanford Medicine (1996); Policlinico San Matteo Fondazione (2006); Society for Cardiovascular Angiography and Interventions (2005–2007); John L. McClellan Memorial Veterans Hospital (2018–2025); Imperial College London (1999–2000); University of Virginia (2013); The Ohio State University (1986); University of Rochester (1989); The University of Texas Medical Branch at Galveston (1995–2011); The University of Adelaide (1999–2000); Columbia University (1996–2017); University of Birmingham (2006); The University of Texas Southwestern Medical Center (2017); University of Gothenburg (1995–1999); Stanford University (1996)
Internal Med, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Barry F. Uretsky's research focuses on cardiovascular disease, particularly myocardial infarction and heart failure. He has contributed to the "Third universal definition of myocardial infarction" in multiple publications, highlighting the evolving understanding and diagnosis of this condition. His work also includes investigations into the treatment of chronic heart failure, specifically examining the comparative effects of different doses of angiotensin-converting enzyme inhibitors like Lisinopril on morbidity and mortality.
Further research interests encompass perioperative cardiovascular evaluation and management for patients undergoing noncardiac surgery, as reflected in his co-authorship of ACC/AHA guidelines. Uretsky has also explored the use of continuous intravenous epoprostenol for primary pulmonary hypertension. His scholarly output is substantial, with a high-impact designation indicated by an h-index of 69, over 550 publications, and more than 32,000 citations. He actively collaborates with researchers at the University of Arkansas for Medical Sciences and the University of Arkansas at Fayetteville.
Metrics
- h-index: 68
- Publications: 551
- Citations: 32,229
Positions
-
Professor publications 2008–2026University of Arkansas for Medical Sciences Internal Med, College of Medicine Institutional directory
Selected Publications
-
Evaluation and Treatment of Myocardial Bridging by Clinical Phenotype (2026)
-
Pathophysiological Mechanisms of Myocardial Bridging-Related Angina and Ischemia with Implications for Therapeutic Strategies (2026)
-
100.22 Dual-Guidewire Balloon-Catheter Design for Coronary Bifurcations (2026)
-
Knowledge gaps in revascularization strategies in the setting of type II myocardial infarction: A common clinical dilemma in contemporary practices (2026)
-
Diagnostic and prognostic utility of fractional flow reserve for in-stent restenosis (2025)
-
Target Heart Rate Formulas for Exercise Stress Testing: What Is the Evidence? (2024)
-
Use of Plaque Modification Microcatheters During Percutaneous Coronary Interventions for Chronic Total Occlusion: Insights From the PROGRESS‐CTO Registry (2024)
-
Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention (2024)
-
Differential Impact of Fractional Flow Reserve Measured After Coronary Stent Implantation by Left Ventricular Dysfunction (2023)
-
Do We Still Need Aspirin in Coronary Artery Disease? (2023)
-
Impact of Post-PCI FFR Stratified by Coronary Artery (2023)
-
Machine-learning-based prediction of fractional flow reserve after percutaneous coronary intervention (2023)
-
Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications (2023)
-
STAR procedure becomes SAFER: First‐in‐man case series of a new antegrade dissection re‐entry technique (2023)
-
Who Should Be the Corresponding Author, What Are Their Responsibilities, and What Email Address Should They Provide? (2023)
Collaboration Network
Top Collaborators
- Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes
- Prognostic Implications of Fractional Flow Reserve After Coronary Stenting
- Effectiveness of Percutaneous Coronary Intervention With Drug‐Eluting Stents Compared With Bypass Surgery in Diabetics With Multivessel Coronary Disease: Comprehensive Systematic Review and Meta‐analysis of Randomized Clinical Data
- Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve
- U.S. Trends in Inpatient Utilization of Fractional Flow Reserve and Percutaneous Coronary Intervention
Showing 5 of 20 shared publications
- Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes
- Impact of Post-PCI FFR Stratified by Coronary Artery
- Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes
- Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention
- Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization
Showing 5 of 11 shared publications
- Prognostic Implications of Fractional Flow Reserve After Coronary Stenting
- Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of “vessel architecture”
- Contrast modulation in chronic total occlusion percutaneous coronary intervention
- Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization
- STAR procedure becomes SAFER: First‐in‐man case series of a new antegrade dissection re‐entry technique
Showing 5 of 9 shared publications
- Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of “vessel architecture”
- Treatment of the chronic total occlusion: A call to action for the interventional community
- Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade
- Contrast modulation in chronic total occlusion percutaneous coronary intervention
- Developments in coronary chronic total occlusion percutaneous coronary interventions: 2014 state-of-the-art update.
Showing 5 of 8 shared publications
- Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention
- Effectiveness of colchicine for the prevention of recurrent pericarditis and post-pericardiotomy syndrome: an updated meta-analysis of randomized clinical data
- Trans-Stent FFR Gradient as a Modifiable Integrant in Predicting Long-Term Target Vessel Failure
- Optimization of stent implantation using a high pressure inflation protocol
- Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program
Showing 5 of 7 shared publications
- Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes
- Effectiveness of Percutaneous Coronary Intervention With Drug‐Eluting Stents Compared With Bypass Surgery in Diabetics With Multivessel Coronary Disease: Comprehensive Systematic Review and Meta‐analysis of Randomized Clinical Data
- Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve
- Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes
- Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization
Showing 5 of 7 shared publications
- Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of “vessel architecture”
- Treatment of the chronic total occlusion: A call to action for the interventional community
- Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade
- Contrast modulation in chronic total occlusion percutaneous coronary intervention
- Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization
Showing 5 of 6 shared publications
- Prognostic Implications of Fractional Flow Reserve After Coronary Stenting
- U.S. Trends in Inpatient Utilization of Fractional Flow Reserve and Percutaneous Coronary Intervention
- Safety and efficacy of device closure for patent foramen ovale for secondary prevention of neurological events: Comprehensive systematic review and meta-analysis of randomized controlled trials
- Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications
- Machine-learning-based prediction of fractional flow reserve after percutaneous coronary intervention
Showing 5 of 6 shared publications
- Do We Really Need Aspirin Loading for STEMI?
- Target Heart Rate Formulas for Exercise Stress Testing: What Is the Evidence?
- How electrically silent is the pericardium?
- Do We Still Need Aspirin in Coronary Artery Disease?
- Closing the Digitalis Divide: Back to the Basics of Randomized Controlled Trials
Showing 5 of 6 shared publications
- Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of “vessel architecture”
- Treatment of the chronic total occlusion: A call to action for the interventional community
- Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade
- Contrast modulation in chronic total occlusion percutaneous coronary intervention
- STAR procedure becomes SAFER: First‐in‐man case series of a new antegrade dissection re‐entry technique
- Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention
- Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization
- Use of Plaque Modification Microcatheters During Percutaneous Coronary Interventions for Chronic Total Occlusion: Insights From the PROGRESS‐CTO Registry
- LB-4 | Contemporary In-Hospital Outcomes and Temporal Trends of Chronic Total Occlusion Percutaneous Coronary Interventions: Insights from the PROGRESS-CTO International Registry
- B-18 | Procedural Time and Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights from the PROGRESS-CTO Registry
- Prognostic Implications of Fractional Flow Reserve After Coronary Stenting
- Impact of Post-PCI FFR Stratified by Coronary Artery
- Clinical and Vessel Characteristics Associated With Hard Outcomes After PCI and Their Combined Prognostic Implications
- Machine-learning-based prediction of fractional flow reserve after percutaneous coronary intervention
- Differential Impact of Fractional Flow Reserve Measured After Coronary Stent Implantation by Left Ventricular Dysfunction
- The use of radiographic contrast media during PCI: A focused review
- Quality assessment and improvement in interventional cardiology: A position statement of the Society of Cardiovascular Angiography and Interventions, part 1: Standards for quality assessment and improvement in interventional cardiology
- Quality assessment and improvement in interventional cardiology: A position statement of the society of cardiovascular angiography and interventions, Part II: Public reporting and risk adjustment
- Evaluation and Treatment of Myocardial Bridging by Clinical Phenotype
- Subadventitial techniques for chronic total occlusion percutaneous coronary intervention: The concept of “vessel architecture”
- Treatment of the chronic total occlusion: A call to action for the interventional community
- Predictors of restenosis following contemporary subintimal tracking and reentry technique: The importance of final TIMI flow grade
- Developments in coronary chronic total occlusion percutaneous coronary interventions: 2014 state-of-the-art update.
- Utilizing Post-Intervention Fractional Flow Reserve to Optimize Acute Results and the Relationship to Long-Term Outcomes
- Clinical and prognostic value of poststenting fractional flow reserve in acute coronary syndromes
- Clinical and angiographic predictors of persistently ischemic fractional flow reserve after percutaneous revascularization
- Clinical Decision-Making for the Hemodynamic "Gray Zone" (FFR 0.75-0.80) and Long-Term Outcomes.
Similar Researchers
Based on overlapping research topics